Lb Pharmaceuticals

LBRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.376 B

$48.00 -0.37%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$25.2M

Loss-making

Shares outstanding

28,674,827

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#142Oric PharmaceuticalsORIC$1.40B
#143Phibro Animal HealthPAHC$1.39B
#144Lb PharmaceuticalsLBRX$1.38B
#145Xeris BiopharmaXERS$1.37B
#146SchrodingerSDGR$1.36B

Where these numbers come from

Share counts and financials for Lb Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.